Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Chemed Inc (CHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,048,210
  • Shares Outstanding, K 15,934
  • Annual Sales, $ 1,783 M
  • Annual Income, $ 205,540 K
  • 60-Month Beta 1.20
  • Price/Sales 2.90
  • Price/Cash Flow 21.60
  • Price/Book 8.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 2.98
  • Number of Estimates 2
  • High Estimate 3.00
  • Low Estimate 2.95
  • Prior Year 2.72
  • Growth Rate Est. (year over year) +9.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
313.49 +1.34%
on 04/17/19
330.49 -3.87%
on 03/21/19
-11.07 (-3.37%)
since 03/18/19
3-Month
282.11 +12.62%
on 01/22/19
334.97 -5.16%
on 03/01/19
+33.69 (+11.86%)
since 01/18/19
52-Week
260.03 +22.18%
on 12/21/18
335.99 -5.44%
on 05/21/18
+23.74 (+8.08%)
since 04/18/18

Most Recent Stories

More News
Here's Why You Should Invest in Chemed (CHE) Stock Right Now

Chemed (CHE) is expected to benefit from the launch of its VITAS Healthcare Inpatient Hospice Unit.

CHE : 317.60 (+0.25%)
AMED : 117.75 (+1.82%)
VAR : 129.82 (-1.40%)
PEN : 128.64 (+1.43%)
Here's Why You Should Hold on to DaVita (DVA) Stock Now

DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, rising expenses remain a dampener.

CHE : 317.60 (+0.25%)
AMED : 117.75 (+1.82%)
DVA : 52.24 (+2.33%)
ADUS : 62.97 (+2.37%)
Chemed To Report First-Quarter 2019 Earnings April 29, Related Conference Call To Be Held On April 30

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2019, on Monday, April 29, 2019, following the close of trading...

CHE : 317.60 (+0.25%)
Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel

Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel

MEI : 29.87 (+0.40%)
ZEUS : 15.80 (-1.99%)
CHE : 317.60 (+0.25%)
MRKR : 5.48 (+0.37%)
WD : 53.39 (-0.09%)
These 5 Stocks Make Great Buys on New Analyst Coverage

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

MEI : 29.87 (+0.40%)
ZEUS : 15.80 (-1.99%)
CHE : 317.60 (+0.25%)
MRKR : 5.48 (+0.37%)
WD : 53.39 (-0.09%)
Why Is Chemed (CHE) Up 2.7% Since Last Earnings Report?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CHE : 317.60 (+0.25%)
Chemed (CHE) Upgraded to Strong Buy: What Does It Mean for the Stock?

Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CHE : 317.60 (+0.25%)
Chemed Corporation to Present at the Oppenheimer 29th Annual Healthcare Conference

Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Oppenheimer 29th Annual Healthcare Conference on Tuesday, March 19, 2019, at approximately 8:35a.m....

CHE : 317.60 (+0.25%)
Zacks.com featured expert Kevin Matras highlights: Balchem, Methode Electronics, Chemed, Ubiquiti Networks and HEXO

Zacks.com featured expert Kevin Matras highlights: Balchem, Methode Electronics, Chemed, Ubiquiti Networks and HEXO

MEI : 29.87 (+0.40%)
CHE : 317.60 (+0.25%)
UBNT : 167.00 (+0.40%)
HEXO : 6.78 (+1.95%)
BCPC : 98.03 (+0.04%)
5 Stocks in Focus on New Analysts Coverage

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

MEI : 29.87 (+0.40%)
CHE : 317.60 (+0.25%)
UBNT : 167.00 (+0.40%)
HEXO : 6.78 (+1.95%)
BCPC : 98.03 (+0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade CHE with:

Business Summary

Chemed Corporation is the nation's largest provider of end-of-life hospice care services through its VITAS Healthcare Corporation subsidiary. Chemed also maintains a presence in the residential and commercial repair-and-maintenance industry through two subsidiaries. Roto-Rooter is North America's largest...

See More

Key Turning Points

2nd Resistance Point 329.72
1st Resistance Point 323.27
Last Price 317.60
1st Support Level 311.93
2nd Support Level 307.04

See More

52-Week High 335.99
Last Price 317.60
Fibonacci 61.8% 306.97
Fibonacci 50% 298.01
Fibonacci 38.2% 289.05
52-Week Low 260.03

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar